Pfizer Inc. recalls 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous
Pfizer recalls 4.2% sodium bicarbonate injection (5 mEq/10mL) with glass particles that could cause injury during IV use. This product was sold in specific lots and packaging.
Use caution until it’s fixed
Presence of Particulate Matter; identified as glass
Contact the company & request your remedy
What happened, in plain English
Pfizer has recalled a specific type of sodium bicarbonate injection that contains glass particles. Using this product could cause injury if particles enter the bloodstream during intravenous administration. Read more at govinfonow.com/recall/32915-pfizer-recalls-sodium-bicarbonate-injection-with-glass-particles-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32915-pfizer-recalls-sodium-bicarbonate-injection-with-glass-particles-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0233-2024
Cite this page
“Pfizer recalls sodium bicarbonate injection with glass particles risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32915-pfizer-recalls-sodium-bicarbonate-injection-with-glass-particles-risk. Based on FDA recall #D-0233-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0233-2024%22&limit=1).
Why it’s dangerous
Glass particles in the injection can enter the bloodstream during intravenous use, potentially causing tissue damage or other complications. This occurs because the glass container may have microscopic particles that are not visible to the naked eye.
Who’s affected
Healthcare professionals who use this injection for intravenous treatments. Patients receiving this medication under medical supervision are at risk if the product is used without proper checks.
How to tell if you have this one
Check for the product name '4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL)' with a glass syringe. Look for the lot number GX1542 and expiration date 01/01/2025 on the packaging.
- Brand
Pfizer- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Ongoing- Distribution
Nationwide in the USA and Puerto Rico.
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0233-2024 | 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).; Lot GX1542, Exp. 01/01/2025 | 34000 Cartons | — |
| D-0234-2024 | 8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).; Lot HA7295, EXP 03/01/2025 | 21200 Cartons | 0409-4916-24, 0409-4916-14, 0409-6637-24, 0409-6637-14 |
| D-0235-2024 | Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).; Lot GY2496, Exp 02/01/2025 | 24400 Cartons | 0409-1630-15, 0409-1630-10, 0409-9630-15, 0409-9630-05, 0409-4910-11, 0409-4910-34, 0409-4911-11, 0409-4911-34 |
What to do — step by step
Check Product Details
Verify the product name, lot number (GX1542), and expiration date (01/01/2025) on the packaging.
Questions people ask
Is this product safe to use?
No, this product contains glass particles that could cause injury during intravenous use. Do not use it.
How can I tell if I have the recalled product?
Check for the product name '4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL)' with a glass syringe and lot number GX1542 with expiration 01/01/2025.
What should I do if I have this product?
Do not use it. Contact your healthcare provider for guidance on safe alternatives.
Contact Pfizer
We’ve drafted a message you can send Pfizer to request your refund or repair — edit it as you like.
Subject: Recall D-0233-2024 — Pfizer Pfizer Hello, I own a Pfizer that is covered by recall D-0233-2024 from Pfizer. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0233-2024 (December 21, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0233-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.